Home › The Resignation Of Osiris Therapeutics' Auditor Really Opens The Door For More Accounting Concerns
 

Keywords :   


The Resignation Of Osiris Therapeutics' Auditor Really Opens The Door For More Accounting Concerns

2015-12-18 22:26:04| Biotech - Topix.net

OSIR has had issues surrounding revenue recognition and internal controls over financial reporting, and this auditor resignation does nothing to suggest that these issues are over. OSIR has had problems collecting on its accounts receivable balance, and has had negative operating cash flow despite positive net income.

Tags: door accounting concerns opens

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Sheboygan Paint Company Names New Regional Sales Managers
08.11Irritants could disrupt U.S., Mexico trade relationship
08.11Irritants could disrupt U.S., Mexico trade relationship
08.11Atlantic Tropical Weather Outlook
08.11Eastern North Pacific Tropical Weather Outlook
08.11African swine fever, labor and trade top of mind for Canadian pork industry
08.11Tech giants dominate U.S. streaming platform market
08.11Warner Bros. Discovery adds 7.2 million DTC subscribers in 3Q 2024
More »